---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-023167"
form_type: "8-K"
ticker: "OM"
cik: "0001484612"
company_name: "Outset Medical, Inc."
filed_at: "2025-02-19T23:59:59+00:00"
generated_at: "2026-05-26T11:22:39.159858+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Outset Medical Q4 revenue $29.5M, beats guidance; 2025 outlook $115-125M revenue, high-30% gross margin

## Summary
- Q4 revenue $29.5M (+3% QoQ, -3% YoY); full-year $113.7M, beating prior guidance.
- Q4 GAAP gross margin 36.5% (37.7% non-GAAP), up 11pp YoY; recurring revenue up 21% to $83.9M in 2024.
- Q4 net loss $25.6M ($0.49/sh) vs $38.6M ($0.77/sh) YoY; non-GAAP loss $19.3M ($0.37/sh).
- Tablo installed base ~6,000 consoles (+10% in 2024); cash $162M at yr-end, ~$210M after Jan 2025 financing.
- 2025 guidance: revenue $115-125M, non-GAAP gross margin high-30% range; cash burn <$50M vs $103M in 2024.

## SEC filing metadata
- accession: 0000950170-25-023167
- form_type: 8-K
- ticker: OM
- cik: 0001484612
- company_name: Outset Medical, Inc.
- filed_at: 2025-02-19T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484612/000095017025023167/0000950170-25-023167-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484612/000095017025023167/om-20250219.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-023167
- JSON: https://secwatch.observer/filing/0000950170-25-023167.json
- Plain text: https://secwatch.observer/filing/0000950170-25-023167.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.